Apyx Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Apyx Medical generated cash of -$5,249,000, which is more than the previous year. Cash used in financing activities reached the amount of $32,166,000 last year. Net change in cash is therefore $33,460,000.
Cash Flow
| 2014 | -417K | -630K | -1.14M |
|---|---|---|---|
| 2015 | -5.78M | -921K | 12.77M |
| 2016 | -2.83M | -286K | 5.77M |
| 2017 | -3.70M | -624K | -179K |
| 2018 | -21.01M | 29.30M | -2.49M |
| 2019 | -18.47M | 60.54M | 147K |
| 2020 | -16.06M | -581K | -73K |
| 2021 | -10.44M | -723K | 24K |
| 2022 | -20.28M | -1.01M | 217K |
| 2023 | -5.24M | 6.73M | 32.16M |
APYX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.19M | 30.87M | 41.91M | 58.81M | 16.59M | 10.66M | 14.45M | 11.80M | 5.73M | 7.92M |
Operating activities | ||||||||||
Net income | -18.85M | -23.27M | -15.2M | -11.90M | -19.70M | 64.00M | -5.06M | -3.95M | -5.37M | -17.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 692K | 890K | 903K | 887K | 754K | 669K | 696K | 734K | 812K | 876K |
Stock-based compensation expense | 5.11M | 6.69M | 5.08M | 4.21M | 3.58M | 0 | 871K | 809K | 575K | 388K |
| Deferred income tax benefit | 5.11M | 6.69M | 5.08M | 4.21M | 3.58M | 0 | 871K | 809K | 575K | 388K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 3.97M | 1.91M | -4.90M | -558K | -3.97M | -382K | -303K | -1.88M | -933K | -3K |
Inventories | 1.45M | -5.56M | -2.85M | 615K | -2.36M | -881K | -870K | -379K | -102K | 1.95M |
Accounts payable | 25K | 67K | 1.15M | -965K | 1.05M | -224K | -23K | 392K | -189K | 494K |
Cash generated by operating activities | -5.24M | -20.28M | -10.44M | -16.06M | -18.47M | -21.01M | -3.70M | -2.83M | -5.78M | -417K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -18.88M | -87.18M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -533K | -1.01M | -723K | -581K | -1.30M | -363K | -624K | -286K | -421K | -630K |
Acquisitions Net | 0 | 0 | 195K | 0 | -80.72M | 91.09M | 0 | 0 | -500K | 0 |
Cash generated by investing activities | 6.73M | -1.01M | -723K | -581K | 60.54M | 29.30M | -624K | -286K | -921K | -630K |
Financing activities | ||||||||||
Common Stock Issued | 2.71M | 365K | 67K | 148K | 207K | 202K | 0 | 5.83M | 11.53M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 35.03M | -148K | -238K | -369K | -60K | -2.69M | -239K | -240K | -239K | -3.25M |
Cash used in financing activities | 32.16M | 217K | 24K | -73K | 147K | -2.49M | -179K | 5.77M | 12.77M | -1.14M |
Net Change In Cash | 33.46M | -20.67M | -11.04M | -16.89M | 42.21M | 5.79M | -4.50M | 2.65M | 6.07M | -2.19M |
Cash at end of period | 43.65M | 10.19M | 30.87M | 41.91M | 58.81M | 16.46M | 9.94M | 14.45M | 11.80M | 5.73M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |